1.
U.S. markets recover from steep losses
WASHINGTON, April 26 (UPI) -- The U.S. Justice Department and AstraZeneca have agreed to settle a case involving marketing of Seroquel for off-label uses, sources told The New York Times.
Sources said the Justice Department planned to hold a news conference Wednesday concerning the case.
The case involved marketing of the anti-psychotic drug for unapproved uses. The Times said Monday the British pharmaceutical giant would be settled the case for $520 million.
Among the accusations, the AstraZeneca was accused of failing to disclose that Seroquel increased risk of diabetes.
The drug is approved for use in treatment of bipolar disorder and schizophrenia for patients over 13. Prescribing the drug for other uses is not permitted.
With a strong marketing campaign behind it, however, the drug -- a blockbuster with $4.9 billion in sales in 2009 -- has been found increasingly prescribed for children and the elderly for unapproved uses, the Times said.
Company spokesman Tony Jewell declined to comment.
|
|
|
|
|
|
| Additional Business News Stories | |
JAKARTA, May 24 (UPI) --
Indonesia needs to address loopholes in its moratorium on deforestation, Greenpeace said.
|
LISLE, Ill., May 24 (UPI) --
A new special operations tactical vehicle has been unveiled by three U.S. companies.
|
First-time buyers are driving the expectations that a recovery has begun. Their numbers and market share are growing despite financing roadblocks and competition with investors for entry-level homes. ...
|
It is a whole new ball of wax in Europe these days.
|
| Stories | Photos | People | Comments |
View Caption
